$15 million upfront with a milestone-driven potential additional $15 million related to the Company’s anticipated pivotal clinical trial in Hypoplastic Left Heart Syndrome (HLHS) priced at the market ...

Lexeo Therapeutics, Inc. announced a private placement financing that aims to raise approximately $80 million through the sale of over 20 million shares of its common stock and pre-funded warrants.

Private placement securities continue to offer insurers attractive opportunities to enhance portfolio income, according to a recent Conning report. Conning’s latest Viewpoint commentary, “Private ...

Atai Life Sciences announced a financing deal to raise approximately $50 million by selling 18,264,840 ordinary shares and pre-funded warrants to purchase an additional 4,566,210 shares. The funds ...

CHARLESTOWN, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today ...

Funding from new and existing investors extends anticipated cash runway into the second half of 2027 SAN DIEGO, March 30, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ...

Stephen Twomey has released a new informative resource exploring how private placements function within a self-directed IRA, the rules governing their use, and the potential benefits accredited ...

Stephen Twomey has published an educational resource analyzing the risks associated with 506(b) private placement investments. The article, Risks of 506(b) Private Placements, outlines structural, ...

The landscape of retirement planning may soon change profoundly. With the recent signing of an executive order aimed at allowing 401(k) plans to include alternative investments such as private equity, ...

All monetary amounts are expressed in Canadian Dollars, unless otherwise indicated. TORONTO, Jan. 27, 2026 /PRNewswire/ - IsoEnergy Ltd. (NYSE American: ISOU) (TSX: ISO) (the "Company" or "IsoEnergy") ...